Treatment of childhood febrile illness
Conditions
Interventions
Tanzania (trial ran from 01/02/2004 to 01/05/2005):
Study children N = 1715 children in baseline, 2169 in follow-up (aim was to enrol one under five from each of a minimum of 1200 households). Health
Sponsors
Research Centre in Health of Nouna (Centre de Recherche en Santé de Nouna [CRSN]) (Burkina Faso)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Health workers: all health workers in the district were selected for training 2. Women leaders: all women from the existing women groups in the area were targeted and enrolled if: 2.1. They had completed primary school 2.2. They were a member of an already existing womens group 2.3. They were a resident of the chosen village and expected to live there during the MAMOP study period This gave 36 women of which 25 were randomly selected for the intervention 3. Households: all households in the randomly sampled villages were included 4. Children: children aged six to 59 months
Exclusion criteria
Exclusion criteria: 1. Women leaders who were: 1.1. Illiterate 1.2. Not resident in the MAMOP villages 2. For all: those who did not consent to participating 3. Children: aged less than six months or greater than 59 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study was the proportion of moderate to severe anaemia (haematocrit less than 24%, haemoglobin less than 8 g/L) in children aged six to 59 months. Evaluation of the trial in Burkina Faso was through a baseline and a follow-up survey. In the Tanzanian study: Baseline survey Feb-April 2004 and follow-up survey Feb-April 2005. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Fever and malaria prevalence 2. Prevalence of palpable spleens (Hackett score greater than two) 3. Prevalence of other illnesses 4. Mean species-specific number of blood films positive for malaria parasites 5. Mean species-specific malaria parasite densities 6. Mean haematocrit and haemoglobin values 7. Mean weight 8. In vivo chloroquine resistance Evaluation of the trial in Burkina Faso was through a baseline and a follow-up survey. In the Tanzanian study: Baseline survey Feb-April 2004 and follow-up survey Feb-April 2005. The number of particants in the follow up survey was 2169. | — |
Countries
Burkina Faso, Tanzania
Outcome results
None listed